fbpx JLABS Company News | JLABS


Other news

Want to know more about the JLABS Portfolio?


Read full story

Toronto QuickFire Winner Avoids the Burn

Imagine knowing the exact moment your sunscreen stops working, making painful sunburns and skin damage a thing of the past. That’s exactly what Suncayr, a startup out of JLABS @ Toronto is trying to do with its product SPOT. According to Suncayr CEO, Andrew Martinko, SPOT is the perfect complement to a preexisting sun care regimen. According to Mr. Martinko, the SPOT, which is a round sticker applied to a highly visible area on the skin, changes color once the sunscreen is no longer effective signaling to the user that it’s time to reapply.

Suncayr’s goal is simple: to make it easier for people to improve their health by helping them better manage UV protection.

“Sunscreen is a great tool when used properly,” said Andrew Martinko, CEO and cofounder of Suncayr. “But understanding how the sunscreen protection varies in different environments is what makes SPOT different.”

The Suncayr team believes they have found the secret to mimicking the skin behavior in varying environments to ensure the maximum effectiveness of the sunscreen.

“Our biggest challenge has been in the development process. We thought we’d figured it out, and then we’d introduce a new environment and it wouldn’t be as effective,” said Martinko. “Wavy water versus stagnant water, sweating versus wiping the skin with a towel: all of these things factor in to how long your sunscreen protection lasts.”

Suncayr came to JLABS @ Toronto as a QuickFire Challenge winner in 2016, and found it was a perfect fit for the growing company.

“JLABS was ideal for us as we needed sophisticated lab facilities in order to run experiments, and with the QuickFire Challenge win, we were able to subsidize rent, which was huge for our growing startup,” explained Mr. Martinko. “Additionally, we received great mentorship and guidance that we could not have gotten anywhere else.”

The JLABS @ Toronto team connected Suncayr to the Johnson & Johnson Consumer sun care team, which allowed access to internal subject matter experts and certain UV testing equipment that was not available at JLABS.

“The entire JLABS @ Toronto team and Stefanie Dhanda in the Boston IC have been absolutely fantastic for us,” said Mr. Martinko. “The connections they made for us internally and the access to the Johnson & Johnson sun care team has been pivotal in our development plans.”

Suncayr is launching SPOT in Australia in 2017 with plans to launch in North America in 2018. Most recently, the Suncayr team was featured in the  Forbes under 30 series.

Congratulations Suncayr!



“In the nucleus of trillions of cells in your body, there are 23 pairs of chromosomes that comprise a genome. There are about 6 billion letters in a human genome, that collectively spell out a sort of molecular blueprint. A mutation of just a single letter in that genetic blueprint can literally change your life.”

This is the succinct raison d'être outlined on the website of Toronto-based DNAstack, a company that develops cutting-edge technologies to help scientists discover and treat the causes of genetic diseases. Amazing, isn’t it? If the human genome is a story, a minor “typo” can result in a life-threatening disease.

It was one of these genetic mistakes that presented DNAstack Chief Executive Officer and Co-Founder Marc Fiume’s best friend with a devastating diagnosis – cystic fibrosis, an inherited, incurable, and life-threatening disorder. Fiume took this personal tragedy in stride, honoring his friend by using his story as the inspiration for a new company that would give doctors and patients a leg up on such illnesses.

Thus, DNAstack, a cloud-based platform for genomics data storage, bioinformatics, and sharing was born with the goal of helping researchers find the cause of genetic disease, clinicians diagnose those diseases, and pharmaceutical companies design treatments faster and with more precision than ever before.

And since launching its cloud platform in October 2016, DNAstack is barreling full speed ahead on the road to doing just that – strategically partnering with tech and life science giants along the way. Google, which has embraced DNAstack as an extension of its cloud platform, and Johnson & Johnson Innovation, which last June welcomed DNAstack to its JLABS @ Toronto facility, are just two such examples.

For Fiume, these relationships are “very intentional” and give his company the freedom to “focus on product not sales.” “With JLABS, we have the nimbleness of a startup but the resources of a big company, which allows us to make a big impact quickly,” said Fiume. Among these resources is Rebecca Yu, former Head of JLABS Canada, whom Fiume describes as one of his “biggest champions.” 

With its fresh ideas and knack for grabbing hold of opportunities, DNAstack has expanded quickly – doubling its size, launching two new products, and obtaining non-dilutive financing in its short time at JLABS @ Toronto. The company has also successfully established itself at the forefront of one the hottest (and most important) trends in bioinformatics: democratization of access to genomic data.

While DNAstack has always been free for researchers, earlier this year, the company launched “Workflows,” an application for scalable, reproducible bioinformatics workflows based on open standards. Per DNAstack, Workflows enables anyone with an internet connection to run any genomics data analysis pipeline at any scale – a game changer that is already accelerating research in cancer, autism, and rare disease. 

Fiume is quick to point out, however, that despite its early success, his company (like any other) has faced challenges. 

“The most difficult thing for DNAstack is breaking down traditional mindsets in government and healthcare to make way for the adoption of new, vastly superior technologies that will drastically improve and save lives,” said Fiume. “The reasons why traditional music, video, and bookstores no longer exist are the same reasons that we will see a revolution of health through digitalization.”

In the face of such obstacles, Fiume leans on his team, whom he says are his “most valuable resources.” When asked for his top piece of advice for budding life science entrepreneurs, he says simply “focus, and regularly refocus, [your team] on what matters.”

As a relatively new venture ourselves, in the trenches with our residents to address the world’s most pressing healthcare challenges, we at JLABS couldn’t agree more. We can’t wait to see the additional success the next year brings for DNAstack, and look forward to supporting Fiume and his team every step of the way!